Trade Analytics
Biotechnology
India is ranked 12th in the world in biotech and third in Asia-Pacific.

Indian Biotechnology Industry Analysis

Latest update: November, 2016

Robust growth in Biotech industry

  • Growing at a faster pace, in comparison with the previous years, the Indian biotech industry witnessed YoY growth of 57.14 per cent in FY16; the total industry size stood at US$ 11 billionby FY16 and is estimated to reach US$ 11.6 billion by FY17 
  • Fast-paced growth is likely to continue; the industry is expected to increase in size to US$ 11.6 billion by 2017, driven by a range of factors such as growing demand, intensive R&D activities and strong government initiatives  
Domestic market share of Indian auto component industry

Bio-pharma accounts for majority market share

  • The bio-pharmaceutical segment accounted for largest revenue share of 64 per cent in India biotech industry, during FY16. 
  • In FY16, the bio-services and bio-agri segments accounted for 18.0 per cent and 14.0 per cent of the biotech industry, respectively. 
  • India is becoming a leading destination for clinical trials, contract research and manufacturing activities which is leading to the growth of bio services sector. 
Auto components sector contribution to GDP

 

Last Updated: November, 2016

India is among the top 12 biotech destinations in the world and ranks second in Asia, after China. The Indian biotech industry is likely to experience significant growth on the back of increasing economic prosperity, health consciousness and a billion-plus population base. Current estimates value the industry at US$ 7 billion in FY15, which is expected to grow at 30.46 per cent Compound Annual Growth Rate (CAGR) to US$ 100 billion by FY25.

The sector is divided into five major segments: bio-pharma, bio-services, bio-agri, bio-industrial and bio-informatics. Biotechnology industry’s growth in India is primarily driven by vaccines and recombinant therapeutics. Going forward, India also has the potential to become a major producer of transgenic rice and several Genetically Modified (GM) or engineered vegetables.

The Government of India has taken several initiatives including a biotechnology industry partnership program to develop new technologies and launched a National Rural Healthcare Mission to boost healthcare spending. As per the 12th Five-Year Plan, the government aims to spend US$ 3.7 billion on biotechnology compared to US$ 1.1 billion in the 11th Five-Year Plan to accelerate the pace of research, innovation and development. In addition, the Department of Biotechnology (DBT) has designed the National Biotechnology Development Strategy (NBDS) to strengthen the industry’s human resources and infrastructure while promoting growth and trade. Furthermore, the Government has allowed 100 per cent Foreign Direct Investment (FDI) through the automatic route for manufacturers of drugs and pharmaceuticals. 

Sectoral Presentation (November, 2016)

Download PDF   Download  (Size: 1.32 MB )

Posters

Brand India Pharma

CATALYSING GROWTH

The Indian biotechnology sector is expected to clock US$ 10 billion in revenue by 2015 on the back of emerging opportunities from around the world.

+ More >

Brand India Pharma

IBEF Publications

IBEF Publication

India Now Magazine


India Now Business and Economy

English

+ More Publications >

IBEF Publication

Blog – Perspectives on India More

Powered by the Who's Who of India

author_Almirah1.jpg Reinventing traditional Indian fashion with a modern twist
Aditi Bajpai, Co-Founder & Designer, Almirah

How connecting with Indian crafts and silhouettes is making room for new business models

Almirah, a conscious clothing and bedding label for chi...

author_Anu_P._Mathai_photo_1_-_mobile_photo_1.jpg India’s economy: On a strong foundation
Anu P. Mathai, IES, Chief Executive Officer, IBEF

India's core sector output index grew by 5 per cent year-on-year at 176.1 in September 2016, as compared with 3.2 per cent year-on-year growth recorded in August 2016...

author_unnamed2.jpg Kent RO Systems: All about purity!
Dr. Mahesh Gupta, Chairman & Managing Director, Kent RO Systems Ltd

Kent RO Systems is known for revolutionising the water purification industry in India. The company today commands a market share of about 40 per cent in RO water purifier...

author_Anu_P._Mathai_photo_1_-_mobile_photo_1.jpg Mobile The best way to reach the consumer?
Anu P. Mathai, IES, Chief Executive Officer, IBEF

The mobile phone has become one of the primary devices used by the consumer today across the globe. A similar trend is visible in the Indian market as well. With a total ...

author_Anu_P._Mathai_photo_1_-_mobile_photo_1.jpg Indian film industry to reach US$ 3.7 billion by 2020
Anu P. Mathai, IES, Chief Executive Officer, IBEF

The Indian film industry is expected to grow at a compounded annual growth rate (CAGR) of 11 per cent to reach US$ 3.7 billion by 2020, according to a recently released r...

author_Narayan_51.jpg Decoding GST for manufacturing SMEs
Mr. R. Narayan, Founder & CEO, Power2SME

As the eagerly and anxiously awaited Goods and Services Tax (GST) Bill, 2016 sailed through the Rajya Sabha with two-thirds majority in which 203 members voted i...

ideas More

Ideas

3Nethra - Providing Vision of Hope
K Chandrasekhar founder of Forus Health has created 3Nethra, a compact portable optical diagnostic machine that can be used by ophthalmologists in any place or conditions. The inspiration behind the creation of 3Nethra was to treat preventable blindness, which comprise of 80 per cent of blind population of India, which itself...

JOIN IBEF.org

Join IBEF.org now. Enjoy FREE subscriptions downloads, updates and more.

Error

Already a member?
Login / Retrieve Password